ABCG2 loss-of-function polymorphism predicts poor response to allopurinol in patients with gout

2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia

Dinesh Khanna, John FitzGerald, Puja Khanna et al. · Arthritis Care & Research · 2012 · 1.5K citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +13

Preliminary criteria for the classification of the acute arthritis of primary gout

Stanley L. Wallace, Harry Robinson, Alfonse T. Masi et al. · Arthritis & Rheumatism · 1977 · 1.4K citations

Medicine, Clinical Sciences, Internal Medicine +13

Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairment

Lisa K. Stamp, J O'donnell, Mei Zhang et al. · Arthritis & Rheumatism · 2010 · 228 citations

Pharmacy, Nephrology, Pharmacology +12

Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen B (HLA‐B) genotype and allopurinol dosing: 2015 update

Yoshiro Saito, L. Dudley Stamp, KE Caudle et al. · Clinical Pharmacology & Therapeutics · 2015 · 157 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

An open-label, 6-month study of allopurinol safety in gout: The LASSO study

Michael A. Becker, David Fitzpatrick, Hyon K. Choi et al. · Seminars in Arthritis and Rheumatism · 2015 · 107 citations · Full text

Pharmacy, Pharmacotherapy, Bioavailability +14